*RESILIA tissue tested against tissue from commercially available pericardial valves from Edwards in a juvenile sheep model 1.
No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients.

References

  1. Flameng W, et al. A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model.
    J Thorac Cardiovasc Surg. 2015;149:340–5
  2. World Health Organization. World Health Statistics 2014. Geneva, Switzerland: WHO; 2014. WHO/HIS/HSI/14.1

INSPIRIS valve

The INSPIRIS valve provides an ideal foundation for your patient’s future through:
1. RESILIA tissue
2. Trusted design and features
3. VFit technology